Ex vivo gene therapy involves the genetic modification of cells outside the patient's body, followed by the reintroduction of these modified cells back into the patient. This approach allows for precise control and testing of the genetic alterations before the cells are returned to the body, minimizing potential risks and enhancing therapeutic efficacy.